Natural History of Spinal Muscular Atrophy Type 1 in Taiwan

NCT02466529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111

Last updated 2017-06-22

No results posted yet for this study

Summary

Spinal muscular atrophy (SMA) is an autosomal recessive disorder characterized by degeneration of motor neurons in the spinal cord and caused by mutations of the survival motor neuron 1 (SMN1) gene.

The investigators will conduct a systematic review of the contents and activities collected via a comprehensive case report form. Patients who fulfilled diagnostic criteria for SMA type 1 will be reviewed retrospectively.

Conditions

  • Natural History of Type 1 Spinal Muscular Atrophy (SMA)

Sponsors & Collaborators

  • Biogen

    collaborator INDUSTRY
  • Taipei Medical University WanFang Hospital

    collaborator OTHER
  • Taipei Veterans General Hospital, Taiwan

    collaborator OTHER_GOV
  • Mackay Memorial Hospital

    collaborator OTHER
  • Chang Gung Memorial Hospital

    collaborator OTHER
  • China Medical University Hospital

    collaborator OTHER
  • Chung Shan Medical University

    collaborator OTHER
  • Changhua Christian Hospital

    collaborator OTHER
  • Taichung Veterans General Hospital

    collaborator OTHER
  • Chi Mei Medical Hospital

    collaborator OTHER
  • Cathay General Hospital

    collaborator OTHER
  • Shin Kong Wu Ho-Su Memorial Hospital

    collaborator OTHER
  • Kaohsiung Veterans General Hospital.

    collaborator OTHER
  • National Cheng-Kung University Hospital

    collaborator OTHER
  • Buddhist Tzu Chi General Hospital

    collaborator OTHER
  • Kaohsiung Medical University

    collaborator OTHER
  • Taipei Medical University Shuang Ho Hospital

    collaborator OTHER
  • National Taiwan University Hospital

    collaborator OTHER
  • Taipei Medical University Hospital

    collaborator OTHER
  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Eligibility

Max Age
36 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02466529 on ClinicalTrials.gov